Niagen Bioscience, Inc. (NAGE)
6.53
-0.10
(-1.51%)
USD |
NASDAQ |
Dec 12, 16:00
6.53
0.00 (0.00%)
After-Hours: 20:00
Niagen Bioscience Total Liabilities (Quarterly): 27.46M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| TransMedics Group, Inc. | 590.83M |
| Liquidia Corp. | 253.93M |
| Recursion Pharmaceuticals, Inc. | 352.58M |
| Caris Life Sciences, Inc. | 506.21M |
| CEL-SCI Corp. | 13.31M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 98.14M |
| Shareholders Equity (Quarterly) | 70.68M |
| Debt to Equity Ratio | 0.0432 |
| Current Ratio | 4.122 |
| Net Debt Paydown Yield | 0.00% |